Exceptional responders with invasive mucinous adenocarcinomas: a phase 2 trial of bortezomib in patients with KRAS G12D-mutant lung cancers.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Marc Ladanyi Maureen Shawn Kennedy |
| Publication date | April 1, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |